Study to Assess the Effectiveness and Safety of Lenacapavir for Human Immunodeficiency Virus (HIV) Pre-Exposure Prophylaxis
Volunteer for research and contribute to discoveries that may improve health care for you, your family, and your community!
- for people ages 16 years and up (full criteria)
- Healthy Volunteers
- healthy people welcome
- at UCLA UCSD
- study startestimated completion
Pre-Exposure Prophylaxis of HIV Infection, Infections, Communicable Diseases, HIV Infections, Acquired Immunodeficiency Syndrome, Tenofovir Disoproxil Fumarate Drug Combination Emtricitabine, Oral Lenacapavir (LEN), F/TDF, Sub-cutaneous (SC) Lenacapavir (LEN), PTM F/TDF, PTM Oral LEN, F/TAF (for US participants only)